Endothelial apoptosis decrease following tadalafil administration in patients with arterial ED does not last after its discontinuation

International Journal of Impotence Research

Volumn 23, Issue 5, 2011, Pages 200-205

  La Vignera, S ^a   Condorelli, R A ^a   Vicari, E ^a   D'Agata, R ^a   Calogero, A E ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

ED; endothelial apoptosis; tadalafil discontinuation

Indexed keywords

BIOLOGICAL MARKER; CD45 ANTIGEN; LIPOCORTIN 5; TADALAFIL; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; APOPTOSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM; ERECTILE DYSFUNCTION; FLOW CYTOMETRY; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION 5 SCORE; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT DURATION;

APOPTOSIS; CARBOLINES; CELL-DERIVED MICROPARTICLES; ENDOTHELIUM, VASCULAR; ERECTILE DYSFUNCTION; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; TIME FACTORS;

EID: 80052700941     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.28     Document Type: Article

References (20)

1. Vicari E, Malaguarnera M, La Vignera S, Calzavara F, Battiato C, Calogero AE. Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities. Asian J Androl 2008; 10: 847-853.
2. Costa C, Virag R. The endothelial-erectile dysfunction connection: an essential update. J Sex Med 2009; 6: 2390-2404.
3. Shet AS. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag 2008; 4: 769-774.
4. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143-151.
5. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C et al. Insulin-like growth factor-1 as a vascular protective factor. Circulation 2004; 110: 2260-2265. (Pubitemid 39372511)
6. Esposito K, Ciotola M, Giugliano F, Sardelli L, Giugliano F, Maiorino MI et al. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med 2008; 5: 1436-1442. (Pubitemid 351803109)
7. Park K, Ryu KS, Li WJ, Kim SW, Paick JS. Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apopto-sis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction. Eur Urol 2008; 53: 1282-1288.
8. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008; 179: 779-785.
9. Porst H, Glina S, Ralph D, Zeigler H, Wong DG, Woodward B. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction. J Sex Med 2010; 7: 3487-3494.
10. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5 item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326. (Pubitemid 30052683)
11. Benson CB, Aruny JE, Vickers Jr MA. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. Am J Roentgenol 1993; 160: 71-73. (Pubitemid 23022808)
12. Speel TG, van Langen H, Wijkstra H, Meuleman EJ. Penile duplex pharmaco-ultrasonography revisited: revalidation of the parameters of the cavernous arterial response. J Urol 2003; 169: 216-220. (Pubitemid 35461591)
13. Ryu JK, Zhang LW, Jin HR, Piao S, Choi MJ, Tuvshintur B et al. Derangements in endothelial cell-to-cell junctions involved in the pathogenesis of hypercholesterolemia-induced erectile dysfunction. J Sex Med 2009; 6: 1893-1907.
14. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28: 223-232. (Pubitemid 351161193)
15. Bernard S, Loffroy R, Sérusclat A, Boussel L, Bonnefoy E, Thévenon C et al. Increased levels of endothelial microparti-cles CD144 (VE-cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetec-tor computed tomography (MDCT). Atherosclerosis 2009; 203: 429-435.
16. Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 2010; 26: 140-145.
17. Laufer EM, Reutelingsperger CP, Narula J, Hofstra L. Annexin A5: an imaging biomarker of cardiovascular risk. Basic Res Cardiol 2008; 103: 95-104. (Pubitemid 351356752)
18. Porst H, Rajfer J, Casabé A, Feldman R, Ralph D, Vieiralves LF et al. Long-term safety and efficacy of tadalafil 5mg dosed once daily in men with erectile dysfunction. J Sex Med 2008; 5: 2160-2169.
19. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 2007; 19: 200-207. (Pubitemid 46340840)
20. Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med 2008; 25: 138-146. (Pubitemid 351297651)